US Stock MarketDetailed Quotes

Vir Biotechnology (VIR)

Watchlist
  • 10.330
  • -0.130-1.24%
Close Apr 16 15:59 ET
1.67BMarket Cap-3.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vir Biotechnology (VIR) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Business of powering the immune system to transform lives by discovering and developing medicines68.56M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
Norgine64.27M93.75%
Other3.39M4.94%
United States (US) Customers2.04M2.97%
GlaxoSmithKline Biologicals S.A. (GSK)-1.14M-1.66%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -